µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© 8UL:C?eY
t
@19a6:Co
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© \&qVr1|
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© RBgkC+2
1.Co-stimulators (or co-stimulating molecules) $kz5)vj "
2.NK-kB mg,f> (
3.Immunoglobulin superfamily }>XSp)"{l
4.antigen-presenting cell (APC) <,hBoHZSL
5.death domain ng<`2XgU
6.CCR and CXCR 'IW+"o
7.Lectin (or mitogen) h+^T);h};|
8.Clusters of differentiation, CD) =nL*/
9.B7 family
?RzT0HRd
10.Cytotoxic T lymphocyte, CTL) A0X0t
11.IL-15 and IL-15 receptor (IL-15R) M2EN(Y_k0
12.MHC restriction }Voh5*$E`
13.Affinity-chromatography qRGb3l
14.Cyctosprin A, CsA G-(c+6Mn
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) IP;@unBl
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© KE3
/<0Z
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *f#4S_ws`
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ jrl6):x
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ .-Lqo=o\
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Wkk Nyg,
ÃâÒßѧרҵ£º "qm> z@K
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ (Sv%-8?gs
Ïû»¯ÄÚ¿Æ£º uY~A0I5Z
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ c-=0l)&'D=
ѪҺ²¡Ñ§×¨Òµ£º a*[\edcHU
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿